Johnson & Johnson (NYSE: JNJ) is known as the dividends king for a reason, and its position remains undisputed. On April 14, 2026, the pharmaceutical giant announced an increase in quarterly dividend from $1.30 to $1.34. That’s an increase of 3.1%, anchoring JNJ as a safe harbor during uncertain times. This hike comes despite the US and the global market reeling under pressure from the Israel-Iran war.
This quarter’s payout is the 64th straight dividend hike amid market turbulence. The development indicates that holding Johnson & Johnson stock for the long term is a reliable source of cash flow, as the dividends keep coming. The pharma company has a history of consistent payout increases, rewarding shareholders for the last 50 years.
Johnson & Johnson stock opened Wednesday’s trading bell at the $226 level. Though this week has turned out to be volatile, investors are hopeful that the July earnings call could report bigger revenues. Therefore, JNJ slipping in the indices opens the window for buying the dips and holding on until Q3. The dividend for the last quarter will be paid out on June 9, 2026.
Also Read: 2 Upcoming FDA Decisions To Shape Johnson & Johnson Stock Price
Why Did Johnson & Johnson Stock Dip This Week?
The recent price weakness is linked to the company’s never-ending lawsuits filed by customers against its products. Recently, a Federal Judge in Texas dismissed the pharma company’s attempt to settle around 70,000 lawsuits linked to its talc products and cancer. This gave the medical giant a legal setback as the legal troubles refused to go away. Johnson & Johnson stock will always be under pressure, as the company is forced to fight thousands of individual lawsuits.
Investors are concerned about the financial exposure the medical giant has to go through to fight the litigation. There is no doubt that many more individual cases will pile up, creating further legal headwinds. The Federal Judge rejected the company’s third attempt in the talcum powder-cancer case is causing trouble for Johnson & Johnson stock in April.